Skip to content
OpenCapital
Get started

Pulmonx Corporation LUNG EBIT

EBIT at other companies

Theravance Biopharma logo
Theravance BiopharmaTBPH
-$9.48M+34.3%
Savara logo
SavaraSVRA
-$38.99M-37.1%
LQD
Liquidia CorporationLQDA
$61.5M+274%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$4.3M+11.8%
Intuitive Surgical logo
Intuitive SurgicalISRG
——
United Therapeutics logo
United TherapeuticsUTHR
——

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-43.7%
Enterprise value$50.17M-39.2%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Calculated from Pulmonx Corporation’s reported figures.

−$13.0Moperating income−$13.5Mincome before tax+$976.0Kinterest expense=-$12.96M

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's EBIT?
Pulmonx Corporation (LUNG) reported EBIT of -$12.96M in Q1 2026.
How has Pulmonx Corporation's EBIT changed year-over-year?
Pulmonx Corporation's EBIT increased by 11.0% year-over-year, from -$14.56M to -$12.96M.
What is the long-term trend for Pulmonx Corporation's EBIT?
Over 4 years (2021 to 2025), Pulmonx Corporation's EBIT has grown at a 3.2% compound annual growth rate (CAGR), from -$47.3M to -$53.66M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.